Merck KGaA's 1st in class brain cancer drug cilengitide flunks Ph III

 
• By Eleanor Malone
  
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Dermatological

More from Therapeutic Category